BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2500615)

  • 1. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A; Roca P; Genestar C; Grases F
    Nephron; 1989; 52(2):162-5. PubMed ID: 2500615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
    Ryall RL; Harnett RM; Hibberd CM; Mazzachi BC; Mazzachi RD; Marshall VR
    Br J Urol; 1987 Dec; 60(6):480-8. PubMed ID: 3427328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the relation between citrate and calcium in normal and stone-former subjects.
    Conte A; Roca P; Gianotti M; Grases F
    Int Urol Nephrol; 1990; 22(1):7-12. PubMed ID: 2380005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic.
    Ryall RL; Marshall VR
    Br J Urol; 1983 Feb; 55(1):1-5. PubMed ID: 6824849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans in urolithiasis.
    Nesse A; Garbossa G; Romero MC; Bogado CE; Zanchetta JR
    Nephron; 1992; 62(1):36-9. PubMed ID: 1436289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical risk factors for stone formation in a Scottish paediatric hospital population.
    MacDougall L; Taheri S; Crofton P
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):125-30. PubMed ID: 20144971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should recurrent calcium oxalate stone formers become vegetarians?
    Robertson WG; Peacock M; Heyburn PJ; Hanes FA; Rutherford A; Clementson E; Swaminathan R; Clark PB
    Br J Urol; 1979 Dec; 51(6):427-31. PubMed ID: 534817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stress and risk of urolith formation. I. The influence of stress on lithogenous urinary substances (author's transl)].
    Brundig P; Berg W; Schneider HJ
    Urol Int; 1981; 36(3):199-207. PubMed ID: 7281375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects.
    Ryall RL; Marshall VR
    Clin Chim Acta; 1984 Aug; 141(2-3):197-204. PubMed ID: 6488555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
    Nikkilä MT
    Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.
    Grases F; Costa-Bauzá A; March JG; Masárová L
    Urol Res; 1991; 19(6):375-80. PubMed ID: 1759332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of risk factors in male stone-formers attending a general hospital out-patient clinic.
    Ryall RL; Darroch JN; Marshall VR
    Br J Urol; 1984 Apr; 56(2):116-21. PubMed ID: 6498429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of glycosminoglycans excretion in normal and stone forming subjects: relationship with uric acid excretion.
    Caudarella R; Stefani F; Rizzoli E; Malavolta N; D'Antuono G
    J Urol; 1983 Mar; 129(3):665-7. PubMed ID: 6834573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical relationship between urine composition and urinary stone formation in stone forming patients.
    Abdel-Aziz AF; el-Waseef A; Abou el-Fotouh M
    Int Urol Nephrol; 1996; 28(4):457-64. PubMed ID: 9119628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.